Boule Diagnostics Q2 net loss narrows to SEK 1.7 million; net sales drop 13.3% to SEK 112.2 million year over year

PUBT · 2d ago
Boule Diagnostics Q2 net loss narrows to SEK 1.7 million; net sales drop 13.3% to SEK 112.2 million year over year
  • Boule Diagnostics Q2 net sales fell 13.3% to SEK 112.2 million, on -8% currency effects and -5.3% organic growth.
  • Operating profit slipped to SEK 0.4 million; profit for the period narrowed to a loss of SEK 1.7 million, EPS was SEK -0.04.
  • Gross margin widened 2.2 percentage points to 40.9%; adjusted operating profit eased 25% to SEK 3.3 million.
  • Instrument sales dropped 41.2% to 605; operating cash flow turned negative at SEK -2.4 million, available liquidity was SEK 26.2 million.
  • CEO Johan Folkunger cited Middle East tensions, shipping disruptions in the Straits of Hormuz, and limited US dollar access for regional customers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boule Diagnostics AB published the original content used to generate this news brief on July 17, 2026, and is solely responsible for the information contained therein.